2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone

C179H184F15N31O18 — CID 158395493

IUPAC2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone
SMILESCCN1CCN(c2cc(C(=O)Nc3ccc(C)c(-c4cc(N5CCOCC5)ccn4)c3)cc(C(F)(F)F)c2)CC1.Cc1ccc(C(=O)Cc2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)ccn1.Cc1ccc(NC(=O)c2cccc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)n1.Cc1ccc(NC(=O)c2ccnc(C(C)(C)C)c2)cc1-c1cc(N2CCOCC2)nc(N2CCOCC2)n1.Cc1ccc(NC(=O)c2ccnc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1.Cc1ccc(NC(=O)c2ccnc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(C#N)c(N2CCOCC2)c1
InChIInChI=1S/C30H34F3N5O2.C29H36N6O3.C25H23F3N2O2.C24H20F3N5O2.2C24H24F2N4O3.C23H23F2N5O3/c1-3-36-8-10-37(11-9-36)26-17-22(16-23(18-26)30(31,32)33)29(39)35-24-5-4-21(2)27(19-24)28-20-25(6-7-34-28)38-12-14-40-15-13-38;1-20-5-6-22(31-27(36)21-7-8-30-25(17-21)29(2,3)4)18-23(20)24-19-26(34-9-13-37-14-10-34)33-28(32-24)35-11-15-38-16-12-35;1-17-5-6-19(24(31)14-18-3-2-4-20(13-18)25(26,27)28)15-22(17)23-16-21(7-8-29-23)30-9-11-32-12-10-30;1-15-20(17-10-22(21(12-28)30-13-17)32-5-7-34-8-6-32)11-19(14-29-15)31-23(33)16-3-2-4-18(9-16)24(25,26)27;1-15-3-4-18(28-23(31)16-5-6-27-20(11-16)22(25)26)13-19(15)17-12-21(24(32)29(2)14-17)30-7-9-33-10-8-30;1-15-6-7-18(27-23(31)17-5-3-4-16(12-17)22(25)26)13-19(15)20-14-21(24(32)29(2)28-20)30-8-10-33-11-9-30;1-14-3-4-16(27-22(31)15-5-6-26-19(11-15)21(24)25)12-17(14)18-13-20(23(32)29(2)28-18)30-7-9-33-10-8-30/h4-7,16-20H,3,8-15H2,1-2H3,(H,35,39);5-8,17-19H,9-16H2,1-4H3,(H,31,36);2-8,13,15-16H,9-12,14H2,1H3;2-4,9-11,13-14H,5-8H2,1H3,(H,31,33);3-6,11-14,22H,7-10H2,1-2H3,(H,28,31);3-7,12-14,22H,8-11H2,1-2H3,(H,27,31);3-6,11-13,21H,7-10H2,1-2H3,(H,27,31)
InChIKeyGXMMQCHZOBWVPQ-UHFFFAOYSA-N
MW3342.61 g/mol
LogP29.89
Rot. Bonds35

About 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone

2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone (PubChem CID 158395493) has the molecular formula C179H184F15N31O18 and a molecular weight of 3342.61 g/mol. Its IUPAC name is 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone.

Molecular Properties

Compound Name2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone
PubChem CID158395493
Molecular FormulaC179H184F15N31O18
Molecular Weight3342.61 g/mol
Exact Mass3340.42
IUPAC Name2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone
SMILESCCN1CCN(c2cc(C(=O)Nc3ccc(C)c(-c4cc(N5CCOCC5)ccn4)c3)cc(C(F)(F)F)c2)CC1.Cc1ccc(C(=O)Cc2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)ccn1.Cc1ccc(NC(=O)c2cccc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)n1.Cc1ccc(NC(=O)c2ccnc(C(C)(C)C)c2)cc1-c1cc(N2CCOCC2)nc(N2CCOCC2)n1.Cc1ccc(NC(=O)c2ccnc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1.Cc1ccc(NC(=O)c2ccnc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(C#N)c(N2CCOCC2)c1
InChIInChI=1S/C30H34F3N5O2.C29H36N6O3.C25H23F3N2O2.C24H20F3N5O2.2C24H24F2N4O3.C23H23F2N5O3/c1-3-36-8-10-37(11-9-36)26-17-22(16-23(18-26)30(31,32)33)29(39)35-24-5-4-21(2)27(19-24)28-20-25(6-7-34-28)38-12-14-40-15-13-38;1-20-5-6-22(31-27(36)21-7-8-30-25(17-21)29(2,3)4)18-23(20)24-19-26(34-9-13-37-14-10-34)33-28(32-24)35-11-15-38-16-12-35;1-17-5-6-19(24(31)14-18-3-2-4-20(13-18)25(26,27)28)15-22(17)23-16-21(7-8-29-23)30-9-11-32-12-10-30;1-15-20(17-10-22(21(12-28)30-13-17)32-5-7-34-8-6-32)11-19(14-29-15)31-23(33)16-3-2-4-18(9-16)24(25,26)27;1-15-3-4-18(28-23(31)16-5-6-27-20(11-16)22(25)26)13-19(15)17-12-21(24(32)29(2)14-17)30-7-9-33-10-8-30;1-15-6-7-18(27-23(31)17-5-3-4-16(12-17)22(25)26)13-19(15)20-14-21(24(32)29(2)28-20)30-8-10-33-11-9-30;1-14-3-4-16(27-22(31)15-5-6-26-19(11-15)21(24)25)12-17(14)18-13-20(23(32)29(2)28-18)30-7-9-33-10-8-30/h4-7,16-20H,3,8-15H2,1-2H3,(H,35,39);5-8,17-19H,9-16H2,1-4H3,(H,31,36);2-8,13,15-16H,9-12,14H2,1H3;2-4,9-11,13-14H,5-8H2,1H3,(H,31,33);3-6,11-14,22H,7-10H2,1-2H3,(H,28,31);3-7,12-14,22H,8-11H2,1-2H3,(H,27,31);3-6,11-13,21H,7-10H2,1-2H3,(H,27,31)
InChIKeyGXMMQCHZOBWVPQ-UHFFFAOYSA-N
XLogP29.89
TPSA529.49 Ų
H-Bond Donors6
H-Bond Acceptors43
Rotatable Bonds35
Heavy Atoms243
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003342.61
LogP ≤ 529.89
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1043

Analyze 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone?
The IUPAC name of 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone (CID 158395493) is 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone.
What is the SMILES notation for 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone?
The canonical SMILES for 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone is CCN1CCN(c2cc(C(=O)Nc3ccc(C)c(-c4cc(N5CCOCC5)ccn4)c3)cc(C(F)(F)F)c2)CC1.Cc1ccc(C(=O)Cc2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)ccn1.Cc1ccc(NC(=O)c2cccc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)n1.Cc1ccc(NC(=O)c2ccnc(C(C)(C)C)c2)cc1-c1cc(N2CCOCC2)nc(N2CCOCC2)n1.Cc1ccc(NC(=O)c2ccnc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1.Cc1ccc(NC(=O)c2ccnc(C(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)n1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(C#N)c(N2CCOCC2)c1.
What is the InChIKey of 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone?
The InChIKey is GXMMQCHZOBWVPQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H34F3N5O2.C29H36N6O3.C25H23F3N2O2.C24H20F3N5O2.2C24H24F2N4O3.C23H23F2N5O3/c1-3-36-8-10-37(11-9-36)26-17-22(16-23(18-26)30(31,32)33)29(39)35-24-5-4-21(2)27(19-24)28-20-25(6-7-34-28)38-12-14-40-15-13-38;1-20-5-6-22(31-27(36)21-7-8-30-25(17-21)29(2,3)4)18-23(20)24-19-26(34-9-13-37-14-10-34)33-28(32-24)35-11-15-38-16-12-35;1-17-5-6-19(24(31)14-18-3-2-4-20(13-18)25(26,27)28)15-22(17)23-16-21(7-8-29-23)30-9-11-32-12-10-30;1-15-20(17-10-22(21(12-28)30-13-17)32-5-7-34-8-6-32)11-19(14-29-15)31-23(33)16-3-2-4-18(9-16)24(25,26)27;1-15-3-4-18(28-23(31)16-5-6-27-20(11-16)22(25)26)13-19(15)17-12-21(24(32)29(2)14-17)30-7-9-33-10-8-30;1-15-6-7-18(27-23(31)17-5-3-4-16(12-17)22(25)26)13-19(15)20-14-21(24(32)29(2)28-20)30-8-10-33-11-9-30;1-14-3-4-16(27-22(31)15-5-6-26-19(11-15)21(24)25)12-17(14)18-13-20(23(32)29(2)28-18)30-7-9-33-10-8-30/h4-7,16-20H,3,8-15H2,1-2H3,(H,35,39);5-8,17-19H,9-16H2,1-4H3,(H,31,36);2-8,13,15-16H,9-12,14H2,1H3;2-4,9-11,13-14H,5-8H2,1H3,(H,31,33);3-6,11-14,22H,7-10H2,1-2H3,(H,28,31);3-7,12-14,22H,8-11H2,1-2H3,(H,27,31);3-6,11-13,21H,7-10H2,1-2H3,(H,27,31).
What are the key properties of 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone?
2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone has a molecular weight of 3342.61 g/mol, XLogP of 29.89, 35 rotatable bonds, 6 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 2-tert-butyl-N-[3-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[5-(6-cyano-5-morpholin-4-yl-3-pyridinyl)-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;3-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]benzamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxopyridazin-3-yl)phenyl]pyridine-4-carboxamide;2-(difluoromethyl)-N-[4-methyl-3-(1-methyl-5-morpholin-4-yl-6-oxo-3-pyridinyl)phenyl]pyridine-4-carboxamide;3-(4-ethylpiperazin-1-yl)-N-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-5-(trifluoromethyl)benzamide;1-[4-methyl-3-(4-morpholin-4-yl-2-pyridinyl)phenyl]-2-[3-(trifluoromethyl)phenyl]ethanone is sourced from PubChem (CID 158395493), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).